Estudios en animales y células
La evidencia publicada procede de animales y células. Se publica poco o nada de ensayos controlados en personas.
Esta página es un esbozo
The wiki has this compound's identity from the My-Pepts library, its standing, and what PubMed holds for it. The article, with its studies read and cited, is not written yet. Until it is, the counts below say how much research exists, not what it found.
Qué tan sólida es la evidencia
Hasta dónde ha llegado
Todo medicamento sube la misma escalera. La mayoría de los compuestos nunca llega a lo más alto, y el lugar que ocupa indica cuánto pueden sostener sus afirmaciones.
- Medicamento autorizado
Un regulador ha revisado los ensayos y lo ha autorizado para un uso concreto.
- Fase 3
Ensayos aleatorizados grandes, a menudo con miles de personas, frente a placebo o un tratamiento estándar.
- Fase 2
Ensayos de tamaño medio que miden la dosis frente al efecto en personas con la enfermedad.
- Fase 1 y estudios humanos iniciales
Primeros estudios en personas: seguridad y cómo el organismo lo procesa.
- Células y animales: Vilon
Trabajo de laboratorio y con animales. Un resultado en animales no es un resultado en personas.
- 62
- artículos en PubMed
- 20
- de ellos en personas
- 1
- ensayos aleatorizados
- 2
- revisiones
Un recuento indica cuánto se ha publicado, no lo que encontró. Contado en PubMed: 2026-11-16
Manipulación y reconstitución
Del polvo a una muestra medida
Los mismos cuatro pasos para cualquier vial liofilizado. Manipulación de laboratorio, no uso en una persona.
1. Lea el vial
La etiqueta indica la masa de péptido en el vial, en miligramos. Ese número es el punto de partida de todo cálculo.
2. Añada el diluyente
Se añade un volumen medido de diluyente lentamente, por la pared del vidrio. Haga girar con suavidad; agitar puede dañar un péptido.
3. Calcule la concentración
La concentración es la masa dividida por el volumen: 10 mg en 2 mL son 5 mg por mL.
4. Mida la muestra
El volumen es la masa deseada dividida por la concentración. En una jeringa U-100, 1 mL equivale a 100 unidades.
La calculadora de abajo hace la aritmética y muestra el procedimiento.
As powder
General practice for lyophilized peptides: keep the sealed vial frozen or refrigerated, dry and away from light, and follow the supplier's certificate of analysis.
In solution
Once in solution a peptide is kept refrigerated and used within the period the supplier states. A vial drawn from more than once needs a preserved diluent such as bacteriostatic water.
This is general practice for lyophilized peptides, not data on Vilon itself. The batch's certificate of analysis and the supplier's sheet are the facts to go by. More on storage
Reconstitution calculator
Opens on vial sizes common for research peptides. Change any number. How the arithmetic works
Draw to
10 units
0.1 mL on a U-100 syringe
- Concentration
- 2.5 mg/mL
- Each unit holds
- 25 mcg
- Samples in the vial
- 20
- Sample
- 250 mcg
5 mg in 2 mL is 2.5 mg/mL. 250 mcg of that is 0.1 mL, which reads as 10 units. This is arithmetic for a vial of Vilon; no amount here is a recommendation.
Vilon: en PubMed
What PubMed held for Vilon on November 16, 2026. A count says how much a compound has been studied, not what the studies found: how to read these numbers.
- 62
- papers
- 20
- in humans
- 3
- clinical trials
- 1
- randomized trials
Most relevant on PubMed
Listed by PubMed's own relevance ranking, trials and reviews first. The wiki has not read these into the article unless they are also among its sources.
- [Effect of thymomimetic vilon on blood coagulation system and fibrinolisis in diabetes mellitus type 1 patients of different age]
Randomized trialKuznik BI, Kolesnichenko LR, Kliuchereva NN, et al. Advances in gerontology = Uspekhi gerontologii, 2006. PMID 17152731
- [Application of peptide bioregulator in complex treatment of elderly cancer patients]
TrialIas'kevich LS, Krutilina NI, Kostetskaia TV, et al. Advances in gerontology = Uspekhi gerontologii, 2005. PMID 16075684
- [Effect of vilon on the immunity status and coagulation hemostasis in patients of different age with diabetes mellitus]
TrialKuznik BI, Isakova NV, Kliuchereva NN, et al. Advances in gerontology = Uspekhi gerontologii, 2007. PMID 18306698
- ViLoN-a multi-layer network approach to data integration demonstrated for patient stratification
StudyKańduła MM, Aldoshin AD, Singh S, et al. Nucleic acids research, 2023. PMID 36395816
- Anti-aging peptide bioregulators induce reactivation of chromatin
StudyLezhava T, Monaselidze J, Kadotani T, et al. Georgian medical news, 2006. PMID 16705247
- Studies of the effects of Vilon and Epithalon on gene expression in mouse heart using DNA-microarray technology
StudyAnisimov SV, Bokheler KR, Khavinson VKh, et al. Bulletin of experimental biology and medicine, 2002. PMID 12360356
- Tissue-specific effects of peptides
StudyKhavinson VK Bulletin of experimental biology and medicine, 2001. PMID 11713572
- Effect of vilon on biological age and lifespan in mice
StudyKhavinson VK, Anisimov VN, Zavarzina NY, et al. Bulletin of experimental biology and medicine, 2000. PMID 11140587
Search used: ("Vilon"[tiab]). Run it on PubMed
Enlaces de investigación
- PubMed (opens in a new tab)Every indexed paper, newest first
- ClinicalTrials.gov (opens in a new tab)Registered trials and their status
- Europe PMC (opens in a new tab)Full text where it is open access
- Google Scholar (opens in a new tab)Papers, preprints and who cites them
- PubChem (opens in a new tab)Structure, identifiers and properties
- YouTube (opens in a new tab)Talks and lectures. Check who is speaking
These open a search for Vilon on each site. The wiki has not reviewed what they return: a video or a preprint is not a peer-reviewed result, and none of it is medical advice.